Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shenzhen Lifotronic Technology Co Gross Margin %?
Shenzhen Lifotronic Technology CoSHSE:688389 -0.85%89 Gross Margin % is 61.03% as of Mar. 2026, which is 0% above its 10-year median of 60.93. GuruFocus rates SHSE:688389 with a GF Score™ of 89/100 and a GF Value™ of ¥15.69 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Shenzhen Lifotronic Technology Co ranks better than 65.84% on this metric.
SHSE:688389's Gross Margin % is ranked better than 65.84% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.16
vs SHSE:688389: 62.33
Shenzhen Lifotronic Technology Co had a gross margin of 61.03% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Shenzhen Lifotronic Technology Co (SHSE:688389) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shenzhen Lifotronic Technology Co had a gross margin of 61.03% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shenzhen Lifotronic Technology Co Gross Margin % Related Terms
Shenzhen Lifotronic Technology Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Lifotronic Technology Co Gross Margin % Chart
SHSE:688389 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Shenzhen Lifotronic Technology Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Lifotronic Technology Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Lifotronic Technology Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Shenzhen Lifotronic Technology Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shenzhen Lifotronic Technology Co (SHSE:688389) has a Gross Margin % of 61.03% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shenzhen Lifotronic Technology Co and its competitors. This is near median its historical median of 60.93. Over the past decade, Shenzhen Lifotronic Technology Co's Gross Margin % has ranged from 58.52 to 67.21. According to the industry distribution chart, Shenzhen Lifotronic Technology Co ranks #275 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 34.2%.
Is Shenzhen Lifotronic Technology Co's Gross Margin % too high?
Shenzhen Lifotronic Technology Co's current Gross Margin % of 61.03% is near median its 10-year median of 60.93. Over the past 10 years, this metric has ranged from a low of 58.52 to a high of 67.21. The Medical Devices & Instruments industry median Gross Margin % is 52.16. Shenzhen Lifotronic Technology Co's value of 61.03% is 17% above this industry median. Based on the distribution chart, Shenzhen Lifotronic Technology Co ranks #275 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shenzhen Lifotronic Technology Co has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Lifotronic Technology Co's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Lifotronic Technology Co ranks #275 out of 805 companies for Gross Margin %. This puts Shenzhen Lifotronic Technology Co in the upper half of its industry. The industry median Gross Margin % is 52.16. Shenzhen Lifotronic Technology Co's value of 61.03% is 17% above this benchmark. Historically, Shenzhen Lifotronic Technology Co's own Gross Margin % has ranged from 58.52 to 67.21 over the past decade. While the company's 10-year median is 60.93 vs. the industry median of 52.16, Shenzhen Lifotronic Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.16, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Lifotronic Technology Co's current Gross Margin % of 61.03% is 17% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shenzhen Lifotronic Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Lifotronic Technology Co's current Gross Margin % is 61.03%, which is near median its own 10-year median of 60.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Lifotronic Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Lifotronic Technology Co (SHSE:688389) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥15.69, compared to a current price of ¥10.48 — trading 33.2% below its estimated fair value. The current Gross Margin % is 61.03%, which is near median its 10-year median of 60.93 and 17% above the Medical Devices & Instruments industry median of 52.16. Shenzhen Lifotronic Technology Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shenzhen Lifotronic Technology Co (SHSE:688389), the current Gross Margin % is 61.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen Lifotronic Technology Co (SHSE:688389) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen Lifotronic Technology Co stock appears to be undervalued.
The current stock price of ¥10.48 is trading 33.2% below its estimated GF Value™ of ¥15.69.
GuruFocus considers Shenzhen Lifotronic Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688389:
Gross Margin %: 61.03% (near median its 10-year median of 60.93)
GF Value™: ¥15.69 vs. price of ¥10.48 (33.2% below fair value)
Industry Position: 17% above the Medical Devices & Instruments median (#275 of 805)
No single metric tells the full story. See the SHSE:688389 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen Lifotronic Technology Co Business Description
Shenzhen Lifotronic Technology Co Ltd is a China based company engaged in the development, production and sales of therapeutic and rehabilitation products, in vitro diagnostic equipment and supporting reagents.
89GF Score
Get the complete analysis for SHSE:688389
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688389 has been successfully added to your 
